Butyrate is used as an energy source by intestinal epithelial cells, but it also serves numerous other functions, such as improving gut barrier function, scavenging ammonia, regulating the immune system, reducing oxidative stress, balancing blood glucose levels, and much more. Butyrate production is most commonly associated with fiber fermentation. However, butyrate formation can occur through fermentation of amino acids such as glutamate, lysine, histidine, cysteine, serine, and alanine. Amino acid fermentation typically occurs in less acidic conditions, and while it may result in some SCFA formation, it can also form potentially damaging metabolites such as phenols and ammonia. Gut pH also directly impacts butyrate production. Mildly acidic environments stunt the growth of Bacteroides, but not Firmicutes or Actinobacteria. This has the effect of limiting propionate formation and boosting butyrate formation, particularly at pH of 5.5, compared to a more neutral pH of 6.5-6.8. Lactobacillus species may indirectly boost butyrate production by increasing the acidity of the gut. A healthy carbohydrate diet (HCD) rich in cereal fibre, arabinoxylan, and resistant starch enhances Bifidobacteria and butyrate production, while diets high in refined grains can decrease the production of butyrate. Reducing sugar intake is recommended to increase butyrate production, as it is a signaling molecule for blood sugar control. Studies show that high-fat and high-sodium diets reduce butyrate concentrations. Lower fat, high carbohydrate diets, with plenty of resistant starch, boosts butyrate production and enhances abundance of Faecalibacterium and Blautia. Eubacterium spp., Roseburia spp., Faecalibacterium prausnitzii, and Clostridium cluster XIVa and IV, are primary producers of butyrate.36 Roseburia inulinivorans and Coprococcus catus, switch between butyrate and propionate production depending on the fermentation substrates. It is also worth noting that F. prausnitzii can convert acetate into butyrate, which may contribute to its anti-inflammatory reputation.
Butyricimonas represents a genus of bacteria within the gut microbiome that plays a pivotal role in intestinal health through its metabolic activities. These bacteria are anaerobic, Gram-negative, and belong to the phylum Bacteroidetes. They are notable for their ability to ferment polysaccharides, complex carbohydrates, and fibers, leading to the production of butyrate - a short-chain fatty acid (SCFA) crucial for maintaining colonic health. Butyrate serves several key functions: it is the primary energy source for colonocytes (cells lining the colon), helps in maintaining the integrity of the gut barrier, possesses anti-inflammatory properties, and plays a role in modulating immune responses. The presence and concentration of Butyricimonas provide valuable insights into the individual's gut microbial composition and health. Low levels of Butyricimonas may be associated with various conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and metabolic disorders like obesity and diabetes. Conversely, optimal levels of these bacteria are indicative of a healthy gut microbiome, capable of effective fiber fermentation and SCFA production.
Related to obesity
Related to obesity
is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon.
C-Peptide, measured through the Liquid Chromatography-Tandem Mass Spectrometry (LC/MS/MS) method, represents a significant advancement in medical diagnostics, offering unparalleled accuracy in assessing pancreatic beta-cell function and insulin production. This test is crucial for differentiating type 1 and type 2 diabetes, as well as for identifying insulinoma, a rare pancreatic tumor. The C-Peptide test, especially when combined with LC/MS/MS technology, provides a highly sensitive and specific measure of C-Peptide levels, far surpassing traditional immunoassays in precision. This is particularly important in cases where distinguishing endogenous insulin production from exogenous insulin administration is critical. The test's precision makes it invaluable for evaluating residual beta-cell function in diabetes patients, guiding treatment decisions, and assessing the need for insulin therapy. Additionally, it's instrumental in the investigation of hypoglycemia, especially in post-gastric bypass patients or those suspected of insulin misuse. The role of C-Peptide testing via LC/MS/MS in personalized medicine is growing, as it aids in tailoring treatment plans based on individual beta-cell function, enhancing patient outcomes in diabetes management. With the increasing prevalence of diabetes globally, the demand for accurate diagnostic tools like C-Peptide, LC/MS/MS is surging, making it a focal point in endocrinological research and practice.
C-peptide is a substance made in the pancreas, along with insulin.
accurate way to find out how much insulin your body is making
A liver protein that rises when there is inflammation.
assess the risk of cardiovascular and peripheral vascular disease
C-telopeptide (CTX) measures the rate of bone breakdown and helps assess osteoporosis risk, menopausal bone loss, and treatment response. Learn what elevated CTX levels mean, common causes, and how this bone turnover marker guides long-term bone health management.
Bone resorption marker measuring type I collagen breakdown rate.
A dimorphic fungus
A dimorphic fungus
A dimorphic fungus
Bacterial Pathogens
Bacterial Pathogens